Ariad Reports Third Quarter 2015 Financial Results And Progress On Strategic Objectives

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today reported financial results for the third quarter of 2015, including revenue from sales of Iclusig® (ponatinib). The Company also provided an update on key corporate initiatives and clinical-trial plans.

Help employers find you! Check out all the jobs and post your resume.